ESR1 and breast neoplasm: Estrogen receptor (ER)-positive breast cancers account for 60-70% of all breast cancers, but the remaining 30-40% of breast cancers are ER-negative breast tumors, which do not express ER, a protein with both prognostic and predictive value [2, 3].